Wise, T
Radua, J
Via, E
Cardoner, N
Abe, O http://orcid.org/0000-0002-1180-2629
Adams, T M
Amico, F
Cheng, Y
Cole, J H
de Azevedo Marques PĂ©rico, C
Dickstein, D P
Farrow, T F D
Frodl, T
Wagner, G
Gotlib, I H
Gruber, O
Ham, B J
Job, D E
Kempton, M J
Kim, M J
Koolschijn, P C M P
Malhi, G S
Mataix-Cols, D
McIntosh, A M
Nugent, A C
O'Brien, J T
Pezzoli, S
Phillips, M L
Sachdev, P S
Salvadore, G
Selvaraj, S
Stanfield, A C
Thomas, A J
van Tol, M J
van der Wee, N J A
Veltman, D J
Young, A H
Fu, C H
Cleare, A J
Arnone, D
Article History
Received: 29 October 2015
Revised: 1 March 2016
Accepted: 23 March 2016
First Online: 24 May 2016
Competing interests
: AJC has within the last 3 years received honoraria for speaking from Astra Zeneca and Pfizer; and received research grant support from Lundbeck. MLP is a consultant for Roche Pharmaceuticals. GS is employed by Janssen Pharmaceuticals. DA has received travel grants from Janssen-Cilag and Servier. The remaining authors declare no conflicts of interest.